We are live on
!
Find out more
WCBA
Weaver C. Barksdale & Associates Portfolio holdings
AUM
$105M
1-Year Est. Return
13.81%
This Fund
S&P 500
This Quarter
Est. Return
-10.12%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$4.89M
(-4.4%)
Cap. Flow
+$7.59M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
20.41%
Holding
66
New
5
Increased
54
Reduced
4
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$2.15M |
| 2 |
Unilever
UL
|
+$2.08M |
| 3 |
Comcast
CMCSA
|
+$1.97M |
| 4 |
Merck
MRK
|
+$375K |
| 5 |
Cardinal Health
CAH
|
+$238K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hubbell
HUBB
|
+$1.89M |
| 2 |
Intel
INTC
|
+$1.37M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$864K |
| 4 |
AbbVie
ABBV
|
+$528K |
| 5 |
AT&T
T
|
+$239K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.41% |
| 2 | Healthcare | 17.76% |
| 3 | Industrials | 11.32% |
| 4 | Technology | 10.28% |
| 5 | Energy | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Franklin Resources
BEN
$17B
| $1.44M | 1.34% |
61,711
+3,722
| +6% | +$95.2K |
|
52
Truist Financial
TFC
$63.4B
| $1.43M | 1.33% |
30,086
+1,794
| +6% | +$88.5K |
|
53
JPMorgan Chase
JPM
$956B
| $1.4M | 1.3% |
12,419
+754
| +6% | +$93.4K |
|
54
Medtronic
MDT
$114B
| $1.36M | 1.27% |
15,162
+1,003
| +7% | +$102K |
|
55
3M
MMM
$93.9B
| $1.33M | 1.24% |
12,267
+732
| +6% | +$88.5K |
|
56
Best Buy
BBY
$17.4B
| $1.3M | 1.21% |
19,907
+1,185
| +6% | +$98.8K |
|
57
T. Rowe Price
TROW
$24.3B
| $1.14M | 1.06% |
10,050
+595
| +6% | +$75.6K |
|
|
STOR
58
DELISTED
STORE Capital Corporation
STOR
| $1.07M | 0.99% |
40,883
+2,413
| +6% | +$66.8K |
|
59
Omega Healthcare
OHI
$14.4B
| $1.06M | 0.99% |
37,650
+2,203
| +6% | +$62.7K |
|
|
60
AT&T
T
$165B
| $1.02M | 0.95% |
48,746
-11,961
| -20% | -$239K |
|
61
Marathon Petroleum
MPC
$90B
| $923K | 0.86% |
11,224
-2,024
| -15% | -$189K |
|
|
62
Cardinal Health
CAH
$55.5B
| $219K | 0.2% |
+4,189
| New | +$238K |
|
63
Warner Bros
WBD
$67.4B
| $149K | 0.14% |
+11,132
| New | +$206K |
|
|
64
Hubbell
HUBB
$26.7B
| – | – |
-10,260
| Closed | -$1.89M |
|
|
65
Intel
INTC
$492B
| – | – |
-27,691
| Closed | -$1.37M |
|
|
PARA
66
DELISTED
Paramount Global Class B
PARA
| – | – |
-22,861
| Closed | -$864K |
|
Similar funds
EW
ANBOT
P
SHF
HA
SDP
MAM
AF
Weaver C. Barksdale & Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Weaver C. Barksdale & Associates held 66 positions worth $107M, down 4.4% from $112M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Weaver C. Barksdale & Associates deployed $7.59M of net new capital in Q2 2022, opening 5 new positions and adding to 54 existing holdings. Its largest new stake was Qualcomm: 15,796 shares worth $2.02M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $528K trimmed.
- Weaver C. Barksdale & Associates's largest Q2 2022 buy was Qualcomm: 15,796 shares worth $2.02M.
- Weaver C. Barksdale & Associates added most to Merck in Q2 2022, an estimated $375K increase.
- Weaver C. Barksdale & Associates's biggest Q2 2022 reduction was AbbVie, cutting an estimated $528K.
- Weaver C. Barksdale & Associates fully exited Hubbell in Q2 2022, selling an estimated $1.89M.
- Weaver C. Barksdale & Associates's ten largest holdings make up 20% of its $107M portfolio in Q2 2022.
- Weaver C. Barksdale & Associates opened 5 new positions and closed 3 in Q2 2022.
- Weaver C. Barksdale & Associates's portfolio value fell 4.4% quarter-over-quarter to $107M.
Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2022, filed 11 Aug 2022.